$1.62
arrow_drop_down2.99%Key Stats | |
---|---|
Open | $1.72 |
Prev. Close | $1.71 |
EPS | -1.78 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $11.37M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 1.67 | 1.72 |
52 Week Range | 1.03 | 3.66 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.78 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
Should New Investors Buy Penny Stocks?
BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Tops Revenue Estimates
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.